Dietary Carcinogens for Colorectal Cancer
结直肠癌的膳食致癌物
基本信息
- 批准号:10040844
- 负责人:
- 金额:$ 25.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-10-16 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:Aberrant crypt fociAddressAllelesAmericanAnimal ModelAromatic HydrocarbonsBenignBenzo(a)pyreneBindingBiologicalCancer EtiologyCarcinogensCarcinomaCell physiologyCellsCessation of lifeChronicClinicalColonColonic AdenomaColonic NeoplasmsColorectalColorectal CancerConsensusDNA Sequence AlterationDataDevelopmentDietDiseaseDoseEnvironmentEnvironmental CarcinogensEnvironmental ExposureEnvironmental Risk FactorEpidemiologyEpigenetic ProcessEvolutionExposure toFoodFrequenciesFruitFutureGeneral PopulationGeneticGenetic DiseasesGenetic PolymorphismGenetic Predisposition to DiseaseGenetic RiskGenetic VariationGenomeHeterozygoteHomozygoteHumanHydrocarbonsIn VitroIncidenceIndividualInflammationIngestionInhalationInjuryInterventionInvestigationLinkMalignant NeoplasmsMalignant neoplasm of lungMediatingMessenger RNAMolecularMusMutant Strains MiceMutationNucleotidesOdds RatioOralOrthologous GenePathogenesisPatientsPenetrancePolyadenylationPopulationPopulation StudyPopulations at RiskPositioning AttributePredispositionPrevention strategyPreventivePublic HealthReceptor SignalingRegimenReportingResearchRiskRisk AssessmentRisk FactorsRoleRouteSignal TransductionSingle Nucleotide PolymorphismSodium Dextran SulfateSusceptibility GeneTP53 geneTherapeuticToxic effectToxicologyTumor PromotersUnited StatesUntranslated RNAUrsidae FamilyVariantadenomaattributable mortalitybasecarcinogenicitycolon carcinogenesiscolon tumorigenesiscolorectal cancer preventioncolorectal cancer riskdrinking watergene interactiongenetic risk factorgenetic variantin vivomouse genomemutantnext generationnovelnovel diagnosticsprospectivereceptorresponserisk variantstudy population
项目摘要
Project Summary
Colorectal cancer is the second leading cause of cancer-related death in the United States. About one third of
colorectal cancer deaths are attributable to inherited factors, yet high-penetrance, germline variants that
increase colorectal cancer risk more than 3-fold (like APC) only account for ~5% of all cases. The vast
majority of colorectal cancers involve the interaction of genes with the environment, particularly in
instances involving common low-penetrance variants. Extensive investigation into low-penetrance,
multifactorial predisposition to colorectal cancer is now beginning to bear fruit, with important implications for
understanding disease pathogenesis and developing new diagnostic, preventive, and therapeutic strategies.
However, the role of environmental exposure such as dietary carcinogens in colorectal cancer and its
interaction with genetic susceptibility alleles are not well understood. Epidemiological estimates suggest that
~70% of colorectal cancers are attributable to carcinogens via ingestion. Benzo[a]pyrene (BaP), a ubiquitous
environmental hydrocarbon found in burnt foods and drinking water, has been associated with increased risk of
colorectal cancer. A novel noncoding genetic variant located in the polyadenylation signal of the p53 gene was
recently identified as a low-penetrance genetic risk variant in colorectal cancer. This p53 variant is positioned
uniquely among colorectal cancer-susceptibility alleles in that it is noncoding and present at higher frequency.
About 1 in 50 in general populations, i.e., over 6 million Americans and 100 million people worldwide, carry this
mutant. We have compelling preliminary data establishing a link between exposure to BaP and increased
colorectal cancer incidence associated with the p53 polyadenylation signal variant. Based on this evidence,
we hypothesize that the interaction of environmental BaP and low-penetrance susceptibility alleles is a
significant determinant of CRC pathogenesis. In this application, we propose 2 specific aims to study the
molecular interactions between a dietary carcinogen and a low-penetrance genetic variant of colorectal cancer.
In Aim 1, we will define the colon carcinogenesis profile of BaP and characterize colon tumor incidence in p53
polyadenylation signal mutant mice exposed to BaP. In Aim 2, we will dissect the molecular mechanisms
whereby BaP exposure contributes to colon carcinogenesis in human and mouse cells and in mice with the
p53 polyadenylation signal variant. With the completion of this project, we will have defined BaP as a novel
environmental risk factor and potentially a complete carcinogen for colorectal cancer in susceptible individuals.
We will understand the in vivo and in vitro function of the p53 variant in p53-mediated cellular processes and in
BaP-induced colon tumorigenesis and be able to expand these findings to future patient studies.
项目摘要
结直肠癌是美国癌症相关死亡的第二大原因。约三分之一
结直肠癌死亡可归因于遗传因素,但高突变率,生殖系变异,
增加结肠直肠癌风险超过3倍(如APC)仅占所有病例的~5%。绝
大多数结直肠癌涉及基因与环境的相互作用,特别是在
涉及常见低外显率变体的实例。深入调查了低浓度迷幻药
结直肠癌的多因素易感性现在开始结出果实,这对
了解疾病的发病机制,并开发新的诊断,预防和治疗策略。
然而,环境暴露如饮食致癌物在结直肠癌中的作用及其
与遗传易感性等位基因相互作用还不清楚。流行病学估计表明,
约70%的结直肠癌可归因于通过摄入致癌物。苯并[a]芘(BaP),一种普遍存在的
在烧焦的食物和饮用水中发现的环境碳氢化合物,与增加的风险有关。
结肠直肠癌一种新的非编码基因变异位于p53基因的多聚腺苷酸化信号,
最近被鉴定为结肠直肠癌的低风险遗传变异。这种p53变体定位于
在结直肠癌易感性等位基因中是独特的,因为它是非编码的,并且以更高的频率存在。
在一般人群中约为1/50,即,超过600万美国人和全世界1亿人,
变种人我们有令人信服的初步数据,建立了接触苯并[a]芘和增加
结直肠癌发病率与p53多聚腺苷酸化信号变异相关。基于这些证据,
我们假设环境BaP和低等位基因易感性的相互作用是
CRC发病机制的重要决定因素。在本申请中,我们提出了2个具体目标来研究
饮食致癌物和结肠直肠癌的低转移率遗传变异之间的分子相互作用。
在目标1中,我们将定义BaP的结肠癌发生谱,并描述p53中结肠肿瘤的发生率。
暴露于BaP的多聚腺苷酸化信号突变小鼠。在目标2中,我们将剖析
由此BaP暴露有助于人类和小鼠细胞以及具有以下特征的小鼠中的结肠癌发生:
p53多聚腺苷酸化信号变体。随着这个项目的完成,我们将把BaP定义为一部小说。
环境危险因素和潜在的完整致癌物的大肠癌易感个体。
我们将了解p53变异体在p53介导的细胞过程中的体内和体外功能,
BaP诱导的结肠肿瘤发生,并能够将这些发现扩展到未来的患者研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yong Li其他文献
A chimeric vacuolar Na+/H+ antiporter gene evolved by DNA family shuf?ing confers increased salt tolerance in yeast
由 DNA 家族改组进化而来的嵌合液泡 Na /H 逆向转运蛋白基因可增强酵母的耐盐性
- DOI:
- 发表时间:
2015 - 期刊:
- 影响因子:0
- 作者:
Yong Li;Hailing Gao;Jiang Wu;Wenzhu Guan - 通讯作者:
Wenzhu Guan
Yong Li的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yong Li', 18)}}的其他基金
Optimizing Syngeneic Mouse Models to Target Mutant p53
优化同基因小鼠模型以靶向突变 p53
- 批准号:
10677353 - 财政年份:2023
- 资助金额:
$ 25.33万 - 项目类别:
Cancer Prevention-Interception Against MGUS Progression
癌症预防——阻止 MGUS 进展
- 批准号:
10745010 - 财政年份:2023
- 资助金额:
$ 25.33万 - 项目类别:
Therapeutic Targeting a Non-Hodgkin Lymphoma Driver Using AI
使用人工智能针对非霍奇金淋巴瘤驱动者进行治疗
- 批准号:
10585717 - 财政年份:2022
- 资助金额:
$ 25.33万 - 项目类别:
Modulation of MicroRNAs with Xenobiotics to Target c-Myc
用异生素调节 MicroRNA 以靶向 c-Myc
- 批准号:
10018536 - 财政年份:2019
- 资助金额:
$ 25.33万 - 项目类别:
MYC as a Biomarker in Aggressive Non-Hodgkin Lymphoma
MYC 作为侵袭性非霍奇金淋巴瘤的生物标志物
- 批准号:
10019120 - 财政年份:2019
- 资助金额:
$ 25.33万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 25.33万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 25.33万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 25.33万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 25.33万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 25.33万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 25.33万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 25.33万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 25.33万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 25.33万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 25.33万 - 项目类别:
Research Grant